
Photo taken from Sankalp Arora/X
Jun 17, 2024, 16:36
Sankalp Arora: Describing outcomes of PICALM at EHA24
Sankalp Arora, Hematology/Oncology Fellow at the MD Anderson Cancer Center, shared on X/Twitter:
“Excited to be presenting retrospective data from MD Anderson Cancer Center at EHA24 describing outcomes of PICALM::MLLT10 fusion acute leukemias!
Key takeaways:
– PICALM::MLLT10 fusion leads to acute leukemias with myeloid/lymphoid/mixed phenotype
– Immature cells with mixed immunophenotype and lineage infidelity
– High frequency of Extramedullary disease
– Low response rates to standard induction therapies.”
Visit the article website.
Source: Sankalp Arora/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 21, 2025, 10:45
Feb 21, 2025, 10:07
Feb 21, 2025, 09:58
Feb 21, 2025, 09:54
Feb 21, 2025, 09:45